The Enterprise Value as of December 2025 (TTM) for Stoke Therapeutics, Inc. (STOK) is 1.69B

According to Stoke Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.69B. This represents a change of 173.39% compared to the average of 618.20M of the last 4 quarters.

Stoke Therapeutics, Inc. (STOK) Historical Enterprise Value (quarterly & annually)

How has STOK Enterprise Value performed in the past?

The mean historical Enterprise Value of Stoke Therapeutics, Inc. over the last ten years is 584.10M. The current 1.69B Enterprise Value has changed 28.83% with respect to the historical average. Over the past ten years (40 quarters), STOK's Enterprise Value was at its highest in in the December 2020 quarter at 1.77B. The Enterprise Value was at its lowest in in the September 2023 quarter at -13070893.02.

Stoke Therapeutics, Inc. (STOK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Stoke Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Stoke Therapeutics, Inc. (STOK) Average Enterprise Value

How has STOK Enterprise Value performed in the past?

The current Enterprise Value of Stoke Therapeutics, Inc. (STOK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Stoke Therapeutics, Inc. (STOK) Enterprise Value vs. Peers

How is STOK’s Enterprise Value compared to its peers?

Stoke Therapeutics, Inc.’s Enterprise Value is greater than Intellia Therapeutics, Inc. (925.20M), greater than Upstream Bio, Inc. (1.46B), greater than Ardelyx, Inc. (1.58B), less than Spyre Therapeutics, Inc. (1.96B), greater than Wave Life Sciences Ltd. (1.07B), greater than Zymeworks Inc. (-43935349065.00), greater than Pharvaris N.V. (1.34B), greater than Novavax, Inc. (1.10B), less than BioCryst Pharmaceuticals, Inc. (2.30B), greater than Zenas BioPharma, Inc. (1.55B),

Build a custom stock screener for Stoke Therapeutics, Inc. (STOK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Stoke Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Stoke Therapeutics, Inc. (STOK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Stoke Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.